Subtilin is an antibiotic extracted from the cells of a particular strain of Bacillus subtiliws.3" It is a low molecular weight substance that dialyzes through collodion membranes, is sensitive to light and alkali, and has the structure of a peptide.
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Subtilin is soluble to at least 30 per cent in saltfree acidified solution. The solubility in acid solution is markedly decreased by the presence of salt. In the presence of 0.5 to 1 per cent of sodium chloride the solubility is reduced to approximately 0.5 to 0.2 per cent. The addition of serum to an aqueous solution of subtilin produces a marked precipitation. The antibiotic is probably a basic substance giving water-soluble salts (1) .
The antibacterial spectrum of subtilin (2) is similar to that of penicillin. It seems reasonable to postulate that the antibiotic might prove useful in infections caused by penicillin-fast or penicillinresistant organisms. In addition, subtilin is effective against Mycobacterium tuberculosis which is not antagonized by penicillin.
The low solubility of subtilin in salt solutions and in serum is probably a desirable property in the treatment of infections caused by such organisms as the pneumococcus (3), streptococci (4), micrococci (5), the anthrax bacillus (6) ing a more prolonged effect. However, for the effective treatment of tuberculosis the antibiotic concentration of the tissues must be maintained at a very high level. Unless the solubility of subtilin in the presence of serum can be increased it will be of limited value in the chemotherapy of tuberculosis.
EXPERIMENTAL
The solubility of the antibiotic may be 'improved considerably as follows: l. Dissolve 1.5 gm. of subtilin in 50 ml. of 20 per cent urea in distilled water; 2. dissolve 0.1 gm. of pectin in 50 ml. of distilled water; 3. mix 1. and 2. and let stand overnight at room temperature for a precipitate to settle out. Centrifugate the mixture and decant the clear supernatant liquid. This clear' liquid contains subtilin that is soluble in serum in all proportions and may be administered without any further treatment.
The injection of unmodified subtilin subcutaneously resulted in the formation of very hard nodule-like deposits under the skin. The subtilin was apparently largely precipitated. Sometimes these deposits produced an ulceration of the skin followed by discharge of the insoluble subtilin. Obviously, not many injections could be given.
The addition of urea to a solution of subtilin increases its solubility and prevents precipitation of most of the antibiotic in the presence of serum. The pectin precipitates out that portion of the subtilin that is not soluble in the presence of serum. The removal of the precipitate gives a serumsoluble subtilin that does not produce nodule-like deposits when injected subcutaneously but is completely absorbed.
The project on the chemotherapy of tuberculosis has been under way for a period of approximately three years. At least 15 experiments have been completed involving a total of over 700 guinea pigs. The work has involved proper dosage, number of doses daily, route of injection of subtilin, and preparation of subtilin before injection.
In most experiments a total of 48 guinea pigs were used weighing approximately 500 gm. each. The animals were infected subcutaneously with 0.3 mg. each of Mycobacterium tuberculosis H37Rv grown in Proskauer and Beck's synthetic medium, then divided into four groups. Group 1 animals received subtilin alone; group 2 received streptomycin alone; group 3 received a mixture of subtilin and streptomycin; and group 4 animals served as controls. Treatments were commenced generally the same day that the animals were infected. The antibiotics were injected subcutaneously three times a day at 9 a.m., 3 p.m., and 9 p.m. for 42 consecutive days (six weeks). The results of only the last three experiments are reported here.
Control Guinea Pigs. Animals in this group were inoculated with Mycobacterium tuberculosis Table II . Five of the animals were macroscopically negative. In the others the antibiotic produced only a suppressive effect. Lesions were present in the liver, lungs, or spleen.
Animals Treated with Subtilin. A group of guinea pigs were treated with 22 mg. of subtilin per day (three injections). The results are recorded in Table III . One-half of the animals were treated with a lot of subtilin that exhibited a low tuberculostatic effect; the other half were treated with a quantity of subtilin that showed a high tuberculostatic action. Of the 11 animals in the living embryonic chick heart tissue fragments (7) . A number of subtilin samples, prepared and purified at the Western Regional Research Laboratory, United States Department of Agriculture, have been tested for their tuberculostatic potencies. In view of the known impurity of the antibiotic, the samples showed great variation in their action on the tubercle bacillus. However, subtilin prepared and purified by a method which would give consistently good results might well be used in the treatment of tuberculosis.
Another point which we should like to stress is that the antibiotic may be combined with streptomycin in the chemotherapy of tuberculosis, thereby decreasing the dosage of the latter. By so doing, toxic manifestations of streptomycin may be considerably reduced or perhaps eliminated completely.
